The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
8-[(6-N-Methylcarbamoylpyridin-3-yl)oxy]-4,5-dihydrothieno[3,4-g][1,2]benzisothiazole-6-carboxamide ID: ALA4076395
PubChem CID: 126511899
Max Phase: Preclinical
Molecular Formula: C17H14N4O3S2
Molecular Weight: 386.46
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CNC(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1
Standard InChI: InChI=1S/C17H14N4O3S2/c1-19-16(23)11-5-3-9(7-20-11)24-17-12-10(14(25-17)15(18)22)4-2-8-6-21-26-13(8)12/h3,5-7H,2,4H2,1H3,(H2,18,22)(H,19,23)
Standard InChI Key: NZIVBHCIRGQSRI-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
8.1797 -8.5005 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.7212 -10.3673 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4333 -10.7757 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1453 -9.5424 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1453 -10.3638 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9267 -10.6177 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4096 -9.9531 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
7.9267 -9.2885 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9887 -8.3323 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7212 -9.5424 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4333 -9.1256 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2570 -8.3196 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
5.4359 -8.2381 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.1049 -8.9938 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1815 -11.4025 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6294 -12.0155 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.9885 -11.5740 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.5353 -8.9499 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3436 -8.7822 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6031 -7.9968 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0481 -7.3789 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.2419 -7.5499 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4107 -7.8278 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9608 -8.4427 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.6680 -7.0439 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.7684 -8.2737 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10 2 1 0
2 3 1 0
3 5 1 0
4 11 1 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 1 0
8 4 2 0
8 1 1 0
1 9 1 0
10 11 2 0
11 12 1 0
12 13 1 0
13 14 2 0
14 10 1 0
6 15 1 0
15 16 2 0
15 17 1 0
9 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 9 1 0
20 23 1 0
23 24 1 0
23 25 2 0
24 26 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 386.46Molecular Weight (Monoisotopic): 386.0507AlogP: 2.62#Rotatable Bonds: 4Polar Surface Area: 107.20Molecular Species: NEUTRALHBA: 7HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.75CX Basic pKa: 1.91CX LogP: 1.82CX LogD: 1.82Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.72Np Likeness Score: -0.84
References 1. Ono K, Banno H, Okaniwa M, Hirayama T, Iwamura N, Hikichi Y, Murai S, Hasegawa M, Hasegawa Y, Yonemori K, Hata A, Aoyama K, Cary DR.. (2017) Design and synthesis of selective CDK8/19 dual inhibitors: Discovery of 4,5-dihydrothieno[3',4':3,4]benzo[1,2-d]isothiazole derivatives., 25 (8): [PMID:28302507 ] [10.1016/j.bmc.2017.02.038 ]